MedPath

Importance of dendritic cells in pathogenesis and therapy of conjunctival melanoma

Recruiting
Conditions
C69.0
Conjunctiva
Registration Number
DRKS00016901
Lead Sponsor
niversitätsaugenklinik Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Tissue from patients with conjunctival melanoma, which is histologically confirmed.

Exclusion Criteria

Pretreatment with neoadjuvant immunotherapies, local chemotherapy or radiotherapy

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The aim of the study is to gain a better understanding of dendritic cell subtypes and BRAF expression in conjunctival melanoma.
Secondary Outcome Measures
NameTimeMethod
not applicable
© Copyright 2025. All Rights Reserved by MedPath